Prostate Adenocarcinoma: Clinical Trials

3 trials for Prostate Adenocarcinoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Completed 2, Recruiting 1

Follow Prostate Adenocarcinoma: new trials by email Literature Review of Prostate Adenocarcinoma trials Research Report on Prostate Adenocarcinoma

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of the Change in PSMA Expression in Prostate Cancer in Response to Hormonal Therapy
Piflufolastat, PSMA PET/CT Scan, PSMA PET/MRI scan - Castration Resistant Prostate Cancer, Castration Sensitive Prostate Cancer
Phase 4RecruitingOHSU Knight Cancer Institute802024-06-252026-10-20
Self-Administered Nitrous Oxide (SANO) During Transrectal Prostate Biopsy to Reduce Patient Anxiety and Pain
Self-Administered Nitrous Oxide, Oxygen - Prostate Disease, Malignancy
Phase 4CompletedBeth Israel Deaconess Medical Center1432021-12-122024-01-30
A Study of Effects of Fesoterodine in Men at High Risk for Overactive Bladder/Detrusor Overactivity Post Robotic-Assisted Lap. Prostatectomy
Fesoterodine, Placebo oral tablet - Prostate Adenocarcinoma
Phase 4CompletedAbramson Cancer Center at Penn Medicine32012-01-012020-04-28

Narrower conditions

Anxiety Disorders (1)  ·  Neoplasms (1)  ·  Pain (1)  ·  Prostatic Diseases (1)  ·  Prostatic Hyperplasia (1)  ·  Prostatic Neoplasms (1)

Broader conditions

Genital Diseases (1)  ·  Genital Diseases, Male (1)  ·  Genital Neoplasms, Male (1)  ·  Male Urogenital Diseases (1)  ·  Mental Disorders (1)  ·  Neoplasms by Site (1)  ·  Neurologic Manifestations (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)  ·  Urogenital Diseases (1)  ·  Urogenital Neoplasms (1)

Interventions

2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid (1)  ·  Magnetic Resonance Spectroscopy (1)  ·  Nitrous Oxide (1)  ·  Oxygen (1)  ·  Specimen Handling (1)  ·  fesoterodine (1)

Sponsors

Abramson Cancer Center at Penn Medicine (1)  ·  Beth Israel Deaconess Medical Center (1)  ·  OHSU Knight Cancer Institute (1)

Countries

United States (3)

Top investigators

David Lee, MD (1)  ·  Heidi Rayala, MD, PhD (1)  ·  Nadine Mallak, MD (1)